Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to fund the development of a screening test for Primary Immunodeficiency Disease (PID) that can differentiate individuals with low antibody titers from individuals with normal antibody titers
Grantee
Division
Global Development
Date
MARCH 2018
Region Served
GLOBAL
Committed Amount
$3,672,332
Grant Topic
Polio
Duration (Months)
43
Grantee Location
Seattle, Washington, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.